BIOVIE INC. (BIVIW)

Latest Insider Confidence Score

2025Q4

50.0
Bearish

Company insider confidence (by quarter)

2018Q3 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Sooch Mina — 813,636 Feb 5, 2019
Kumar Hari — 727,272 Mar 13, 2019
Yeramian Patrick D — 300,000 Mar 13, 2019
Palumbo Joseph M Chief Medical Officer 156,000 Jul 12, 2024
Wieland R Richard — 150,000 Sep 4, 2018

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 7, 2025 Aug 13, 2025 DO CUONG V CEO Neutral 90.0 +5,000 100.16% ✗ -
Nov 20, 2024 Jan 7, 2025 ROGICH SIGMUND Director Neutral 90.0 +32,700 773.78% ✗ -
Nov 20, 2024 Jan 7, 2025 BERMAN RICHARD J Director Neutral 90.0 +34,200 530.81% ✗ -
Nov 20, 2024 Jan 7, 2025 Sherman Michael Edward Director Neutral 52.5 - 0.00% ✗ -
Nov 20, 2024 Jan 7, 2025 Lang James Paul Director Neutral 52.5 - 0.00% ✗ -
Nov 20, 2024 Jan 7, 2025 Hariri Robert J Director Neutral 52.5 - 0.00% ✗ -
Dec 20, 2024 Jan 7, 2025 Palumbo Joseph M Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 20, 2024 Jan 7, 2025 KIM JOANNE WENDY CFO Neutral 52.5 - 0.00% ✗ -
Dec 20, 2024 Jan 7, 2025 DO CUONG V CEO Neutral 52.5 - 0.00% ✗ -
Feb 16, 2023 Jul 12, 2024 Palumbo Joseph M Chief Medical Officer Sell 91.3 +82,048 220.87% ✗ $30.3K
Feb 16, 2023 Jul 12, 2024 KIM JOANNE WENDY CFO Sell 91.3 +49,798 20.99% ✗ $25.2K
Feb 16, 2023 Jul 12, 2024 DO CUONG V CEO Sell 95.0 +116,094 12.58% ✗ $53K
Mar 4, 2024 Mar 6, 2024 DO CUONG V CEO Neutral 77.5 +10,000 2.35% ✗ -
Dec 11, 2023 Dec 13, 2023 KIM JOANNE WENDY CFO Neutral 90.0 +5,000 12.77% ✗ -
Nov 9, 2023 Dec 6, 2023 Lang James Paul Director Neutral 52.5 - 0.00% ✗ -
Nov 9, 2023 Dec 6, 2023 GORLIN STEVE Director Sell 22.5 -29,322 -38.74% ✗ $127.9K
Nov 9, 2023 Dec 6, 2023 ROGICH SIGMUND Director Neutral 90.0 +42,254 100.00% ✗ -
Nov 9, 2023 Dec 6, 2023 Hariri Robert J Director Neutral 90.0 +42,254 100.00% ✗ -
Nov 9, 2023 Dec 6, 2023 Sherman Michael Edward Director Neutral 52.5 - 0.00% ✗ -
Nov 9, 2023 Dec 6, 2023 BERMAN RICHARD J Director Neutral 90.0 +51,830 297.79% ✗ -
Nov 30, 2023 Dec 1, 2023 DO CUONG V CEO Buy 78.8 +10,000 2.06% ✗ $17.8K
Sep 5, 2023 Sep 7, 2023 GORLIN STEVE Director Sell 26.3 -8,560 -10.16% ✗ $26.1K
Aug 22, 2023 Aug 24, 2023 BERMAN RICHARD J Director Sell 26.3 -10,805 -39.16% ✗ $37.8K
Jun 7, 2023 Jul 3, 2023 KIM JOANNE WENDY CFO Neutral 52.5 - 0.00% ✗ -
Jun 29, 2023 Jul 3, 2023 DO CUONG V CEO Neutral 90.0 +149,500 54.10% ✗ -
Jun 7, 2023 Jul 3, 2023 Palumbo Joseph M Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jun 21, 2023 Jun 26, 2023 DO CUONG V CEO Neutral 52.5 - 0.00% ✗ -
May 22, 2023 Jun 15, 2023 BERMAN RICHARD J Director Sell 22.5 -10,984 -32.12% ✗ $67.3K
Mar 27, 2023 Apr 6, 2023 BERMAN RICHARD J Director Sell 22.5 -10,984 -24.31% ✗ $93.6K
Feb 16, 2023 Feb 22, 2023 Palumbo Joseph M Chief Medical Officer Sell 46.3 -2,476 -6.25% ✗ $15.2K
Feb 16, 2023 Feb 22, 2023 DO CUONG V CEO Sell 46.3 -4,953 -2.11% ✗ $30.3K
Feb 16, 2023 Feb 22, 2023 KIM JOANNE WENDY CFO Sell 46.3 -2,476 -5.95% ✗ $15.2K
Feb 16, 2023 Feb 22, 2023 Ahlem Clarence N. EVP Neuroscience Product Dev. Sell 46.3 -2,476 -6.25% ✗ $15.2K
Feb 16, 2023 Feb 22, 2023 READING CHRISTOPHER EVP Neuroscience R&D Sell 46.3 -2,476 -6.25% ✗ $15.2K
Feb 16, 2023 Feb 22, 2023 MARKHAM PENELOPE EVP Liver Cirrhosis R&D Sell 46.3 -2,476 -4.92% ✗ $15.2K
Nov 23, 2022 Jan 18, 2023 ROGICH SIGMUND Director Neutral 52.5 - 0.00% ✗ -
Nov 23, 2022 Jan 18, 2023 GORLIN STEVE Director Neutral 90.0 +34,240 68.48% ✗ -
Nov 23, 2022 Jan 18, 2023 Sherman Michael Edward Director Neutral 52.5 - 0.00% ✗ -
Nov 23, 2022 Jan 18, 2023 Lang James Paul Director Neutral 90.0 +43,578 174.01% ✗ -
Nov 23, 2022 Jan 18, 2023 READING CHRISTOPHER EVP Neuroscience R&D Neutral 90.0 +39,624 100.00% ✗ -
Nov 23, 2022 Jan 18, 2023 Hariri Robert J Director Neutral 90.0 +34,240 100.00% ✗ -
Nov 23, 2022 Jan 18, 2023 Palumbo Joseph M Chief Medical Officer Neutral 90.0 +39,624 100.00% ✗ -
Nov 23, 2022 Jan 18, 2023 Ahlem Clarence N. EVP Neuroscience Product Dev. Neutral 90.0 +39,624 100.00% ✗ -
Nov 23, 2022 Jan 18, 2023 BERMAN RICHARD J Director Neutral 90.0 +43,578 2723.63% ✗ -
Nov 23, 2022 Jan 18, 2023 PEIZER TERREN S Director Neutral 52.5 - 0.00% ✗ -
Nov 23, 2022 Jan 18, 2023 KIM JOANNE WENDY CFO Neutral 90.0 +39,624 1981.20% ✗ -
Nov 23, 2022 Jan 18, 2023 DO CUONG V CEO Neutral 90.0 +79,248 50.93% ✗ -
Nov 23, 2022 Jan 18, 2023 MARKHAM PENELOPE EVP Liver Cirrhosis R&D Neutral 90.0 +39,624 370.56% ✗ -
Aug 13, 2018 Aug 26, 2022 PEIZER TERREN S Director Neutral 90.0 +16,380,096 54.12% ✗ -
Aug 15, 2022 Aug 16, 2022 PEIZER TERREN S Director Neutral 90.0 +3,636,364 18.62% ✗ -
Aug 16, 2022 PEIZER TERREN S Director Neutral 52.5 - 0.00% ✗ -
Jun 21, 2022 Jul 7, 2022 DO CUONG V CEO Neutral 52.5 - 0.00% ✗ -
Apr 5, 2022 Apr 25, 2022 Lang James Paul Director Neutral 52.5 - 0.00% ✗ -
Apr 5, 2022 Apr 21, 2022 ROGICH SIGMUND Director Neutral 52.5 - 0.00% ✗ -
Apr 5, 2022 Apr 20, 2022 Sherman Michael Edward Director Neutral 52.5 - 0.00% ✗ -
Apr 5, 2022 Apr 20, 2022 GORLIN STEVE Director Neutral 52.5 - 0.00% ✗ -
Apr 5, 2022 Apr 20, 2022 BERMAN RICHARD J Director Neutral 52.5 - 0.00% ✗ -
Apr 5, 2022 Apr 20, 2022 Hariri Robert J Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2022 Feb 17, 2022 Palumbo Joseph M Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 2, 2022 Feb 16, 2022 Adams Jonathan M EVP Liver Cirrhosis Programs Neutral 27.5 -1,000 -2.01% ✗ -
Dec 31, 2021 Jan 25, 2022 DO CUONG V CEO Neutral 90.0 +21,710 16.21% ✗ -
Dec 7, 2021 Dec 9, 2021 KIM JOANNE WENDY CFO Buy 91.3 +2,000 100.00% ✗ $10.8K
Nov 10, 2021 Palumbo Joseph M Other Neutral 52.5 - 0.00% ✗ -
Jun 16, 2021 Oct 29, 2021 Adams Jonathan M EVP Liver Cirrhosis Programs Neutral 27.5 -10,000 -16.77% ✗ -
Aug 20, 2021 Oct 8, 2021 READING CHRISTOPHER EVP Neuroscience R&D Neutral 52.5 - 0.00% ✗ -
Oct 8, 2021 READING CHRISTOPHER EVP Neuroscience R&D Neutral 52.5 - 0.00% ✗ -
Jan 2, 2020 Sep 29, 2021 BERMAN RICHARD J Director Neutral 90.0 +1,600 100.00% ✗ -
Sep 28, 2021 BERMAN RICHARD J Director Neutral 52.5 - 0.00% ✗ -
Aug 20, 2021 Sep 28, 2021 Ahlem Clarence N. EVP Neuroscience Product Dev. Neutral 52.5 - 0.00% ✗ -
Sep 28, 2021 Ahlem Clarence N. EVP of Product Development Neutral 52.5 - 0.00% ✗ -
Dec 18, 2020 Sep 28, 2021 Hariri Robert J Director Neutral 52.5 - 0.00% ✗ -
Sep 28, 2021 Hariri Robert J Director Neutral 52.5 - 0.00% ✗ -
Aug 20, 2021 Sep 16, 2021 Do Cuong V CEO Neutral 52.5 - 0.00% ✗ -
Aug 20, 2021 Sep 16, 2021 MARKHAM PENELOPE EVP Liver Cirrhosis R&D Neutral 52.5 - 0.00% ✗ -
Aug 20, 2021 Sep 16, 2021 Adams Jonathan M EVP Liver Cirrhosis Programs Neutral 52.5 - 0.00% ✗ -
Aug 20, 2021 Sep 16, 2021 KIM JOANNE WENDY CFO Neutral 52.5 - 0.00% ✗ -
Dec 18, 2020 Mar 5, 2021 GORLIN STEVE Director Neutral 52.5 - 0.00% ✗ -
Dec 18, 2020 Mar 4, 2021 Sherman Michael Edward Director Neutral 52.5 - 0.00% ✗ -
Dec 18, 2020 Mar 4, 2021 ROGICH SIGMUND Director Neutral 52.5 - 0.00% ✗ -
Dec 18, 2020 Mar 4, 2021 Lang James Paul Director Neutral 52.5 - 0.00% ✗ -
Dec 18, 2020 Mar 4, 2021 Do Cuong V Director Neutral 52.5 - 0.00% ✗ -
Nov 3, 2020 Dec 15, 2020 GORLIN STEVE Director Buy 86.3 +2,430 5.69% ✗ $19.3K
Oct 30, 2020 Dec 15, 2020 GORLIN STEVE Director Buy 86.3 +2,570 6.41% ✗ $20.5K
Jun 16, 2020 Nov 16, 2020 ROGICH SIGMUND Director Neutral 52.5 - 0.00% ✗ -
Oct 28, 2020 Yeramian Patrick D Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jun 16, 2020 Oct 23, 2020 GORLIN STEVE Director Neutral 52.5 - 0.00% ✗ -
Oct 23, 2020 WIELAND R RICHARD Director Neutral 52.5 - 0.00% ✗ -
Oct 23, 2020 Anderson Julie G Director Neutral 52.5 - 0.00% ✗ -
Oct 21, 2020 Oct 22, 2020 GORLIN STEVE Director Buy 91.3 +5,000 14.25% ✗ $46K
Oct 22, 2020 Sooch Mina Director Neutral 52.5 - 0.00% ✗ -
Oct 22, 2020 Kumar Hari Director Neutral 52.5 - 0.00% ✗ -
Oct 13, 2020 Oct 21, 2020 Sherman Michael Edward Director Neutral 52.5 - 0.00% ✗ -
Oct 1, 2020 Oct 21, 2020 KIM JOANNE WENDY CFO Neutral 52.5 - 0.00% ✗ -
Jan 2, 2020 Oct 21, 2020 Sherman Michael Edward Director Neutral 85.0 +1,600 8.39% ✗ -
Jan 2, 2020 Oct 21, 2020 Lang James Paul Director Neutral 85.0 +1,600 6.82% ✗ -
Jan 2, 2020 Oct 21, 2020 Do Cuong V Director Neutral 77.5 +1,600 1.68% ✗ -
Jan 19, 2020 Oct 21, 2020 Adams Jonathan M COO Neutral 52.5 - 0.00% ✗ -
Oct 1, 2019 Oct 21, 2020 KIM JOANNE WENDY CFO Neutral 52.5 - 0.00% ✗ -
Jan 19, 2020 Oct 21, 2020 MARKHAM PENELOPE Chief Science Officer Neutral 52.5 - 0.00% ✗ -
Oct 15, 2020 Oct 19, 2020 GORLIN STEVE Director Buy 95.0 +15,100 12.97% ✗ $152.5K